The Expression Pattern and Clinical Significance of Lysyl Oxidase Family in Gliomas

Dokl Biochem Biophys. 2023 Jun;510(1):132-143. doi: 10.1134/S1607672922600269. Epub 2023 Aug 15.

Abstract

LOX (Lysyl oxidase) family participates in the catalysis of collagen and elastin to maintain ECM homeostasis. Glioma is the most common primary brain tumor and LOX family has not been systemic studied in glioma. In this study, we found LOX family members are upregulated expressed in gliomas samples. A protein-protein interaction network (PPIN) was construct to visualize and understand the differential expression pattern, as well as functional annotation, for LOX family and their interacting proteins, which involved in collagen fibril organization and MAPK signaling pathway. Through subcellular localization distribution, the LOX family members distribute both intracellular and extracellular. All five LOX members are consistently significantly correlate with dendritic cell both in immune infiltrate of GBM and LGG. Survival analysis showed that high expression of LOX family is associated with a poor prognosis of gliomas patients. These analyses provide important clues to identify the potential biological roles for LOX family in gliomas, which might serve as diagnosis markers.

Keywords: Lysyl oxidase; expression pattern; functional enrichment; gliomas; protein-protein interaction network.

MeSH terms

  • Clinical Relevance
  • Collagen / metabolism
  • Glioma* / genetics
  • Humans
  • Protein-Lysine 6-Oxidase* / analysis
  • Protein-Lysine 6-Oxidase* / genetics
  • Protein-Lysine 6-Oxidase* / metabolism

Substances

  • Protein-Lysine 6-Oxidase
  • Collagen